OVID THERAPEUTICS DL-,001 revenue breakdown overview

OVID THERAPEUTICS DL-,001 revenue for the last year amounted to 354.88 k EUR, the most of which — 354.88 k EUR — came from its highest performing source at the moment, Novel Therapeutics, the year earlier bringing 1.40 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought OVID THERAPEUTICS DL-,001 354.88 k EUR, and the year before that — 1.40 M EUR.